Fundraising FoxRhapsogen
2 known investors
Find your way into Rhapsogen
Sign up to see every warm intro you have to Rhapsogen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rhapsogen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rhapsogen is developing a precision biologic therapy aimed at treating autoimmune diseases, focused on efficacy, safety, and durability.
Investors · 2
Frequently asked questions
- What does Rhapsogen do?
- Rhapsogen is developing a precision biologic therapy aimed at treating autoimmune diseases, focused on efficacy, safety, and durability.
- Who are Rhapsogen's investors?
- Rhapsogen's investors include Catalio Capital Management, LP, Catalio Capital Management.